ESC Premium Access

Loss of function in PCSK9, atherogenic lipoprotein concentrations, and calcific aortic valve stenosis

Congress Presentation

About the speaker

Doctor Benoit Arsenault

Centre de Recherche de lInstitut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec (Canada)
0 follower

9 more presentations in this session

Lipoprotein particle profiles compared with standard lipids in the association with sub-clinical aortic valve calcification in apparently healthy japanese men

Speaker: Mr T. Vu (Shiga, JP)


Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias

Speaker: Doctor E. Scheirlynck (Brussels, BE)


Advanced glycation end products accumulate in aortic valve tissue during calcification development in the absence of diabetes mellitus. A spectroscopic study.

Speaker: Doctor N. Anousakis-Vlachochristou (Athens, GR)


Hyperinsulinemia, hypertension and two clusters of biomarkers predict aortic stenosis in 10,144 Finnish men.

Speaker: Doctor M. Ojanen (Kuopio, FI)


N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function and prognosis in elderly patients with valvular heart disease.

Speaker: Doctor B. Zhang (Beijing, CN)


Access the full session

Poster Session 5 - Implementing biomarkers for valvular heart disease

Speakers: Doctor B. Arsenault, Mr T. Vu, Doctor E. Scheirlynck, Doctor N. Anousakis-Vlachochristou, Doctor M. Ojanen...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by